Hennion & Walsh Asset Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Hennion & Walsh Asset Management, Inc. holds 94 biotech & pharma companies tracked by BioSniper, totaling $277.5M in value as of Mar 2026 (SEC Form 13F).

Companies held

94

Total value held

$277.5M

CompanySharesValue
LLYELI LILLY & Co14,325$13.2M
COGTCogent Biosciences, Inc.326,472$12.6M
TEVATeva Pharmaceutical Industries Limited337,044$10.2M
INDVIndivior Pharmaceuticals, Inc.330,691$10.1M
JNJJOHNSON & JOHNSON41,172$10.1M
JAZZJazz Pharmaceuticals plc49,352$9.3M
MRKMerck & Co., Inc.73,593$8.9M
MIRMMirum Pharmaceuticals, Inc.93,592$8.6M
MCKMcKesson Corporation9,513$8.2M
DAWNDay One Biopharmaceuticals, Inc.367,134$7.9M
KALVKalVista Pharmaceuticals, Inc.375,995$7.6M
OLMAOlema Pharmaceuticals, Inc.481,485$7.2M
AXSMAxsome Therapeutics, Inc.36,633$6.2M
PMPhilip Morris International Inc36,773$6.1M
ARDXARDELYX, INC.1,001,481$6.0M
ABBVAbbVie Inc.23,382$5.1M
SNDXSyndax Pharmaceuticals Inc214,807$5.0M
SUPNSUPERNUS PHARMACEUTICALS, INC.88,454$4.6M
MDGLMADRIGAL PHARMACEUTICALS, INC.8,616$4.5M
GRFSGrifols S.A.520,136$4.2M
ZLABZai Lab Ltd214,323$4.0M
UNHUnitedHealth Group Incorporated Common Stock (DE)14,743$4.0M
GILDGILEAD SCIENCES, INC.27,272$3.8M
UTHRUNITED THERAPEUTICS Corp6,195$3.7M
PCRXPacira BioSciences, Inc.155,396$3.5M
INCYIncyte Corp.37,138$3.5M
VRDNViridian Therapeutics, Inc.\DE174,894$3.4M
TVTXTravere Therapeutics, Inc.113,511$3.4M
URGNUroGen Pharma Ltd.183,504$3.3M
KNSAKiniksa Pharmaceuticals International, plc67,341$3.2M
IBRXImmunityBio, Inc.407,444$3.1M
MGTXMeiraGTx Holdings plc354,755$3.1M
ANNXAnnexon, Inc.509,689$2.8M
AMGNAMGEN INC7,997$2.8M
KURAKura Oncology, Inc.335,212$2.7M
CMPSCOMPASS Pathways plc487,674$2.7M
HRMYHarmony Biosciences Holdings, Inc.92,354$2.6M
CAHCardinal Health Inc.11,799$2.5M
OCGNOcugen, Inc.1,276,725$2.3M
IMVTImmunovant, Inc.91,009$2.3M
ACADACADIA PHARMACEUTICALS INC100,729$2.2M
ARCTArcturus Therapeutics Holdings Inc.279,679$2.2M
NTLAIntellia Therapeutics, Inc.159,803$2.0M
ORICOric Pharmaceuticals, Inc.160,054$2.0M
APLSApellis Pharmaceuticals, Inc.50,374$2.0M
NUVBNuvation Bio Inc.450,594$1.9M
MLYSMineralys Therapeutics, Inc.70,189$1.9M
CORTCORCEPT THERAPEUTICS INC45,979$1.9M
VRTXVERTEX PHARMACEUTICALS INC / MA4,029$1.8M
RIGLRIGEL PHARMACEUTICALS INC66,242$1.8M
TSHATaysha Gene Therapies, Inc.391,476$1.7M
VERAVera Therapeutics, Inc.42,878$1.7M
ZVRAZEVRA THERAPEUTICS, INC.177,163$1.7M
PHATPhathom Pharmaceuticals, Inc.145,932$1.6M
DGXQuest Diagnostics Incorporated8,240$1.6M
CLDXCelldex Therapeutics, Inc.47,525$1.5M
IOVAIOVANCE BIOTHERAPEUTICS, INC.409,464$1.4M
IMCRImmunocore Holdings plc47,127$1.4M
FLGTFulgent Genetics Inc.84,010$1.3M
ABTABBOTT LABORATORIES12,920$1.3M
LXRXLEXICON PHARMACEUTICALS, INC.848,138$1.3M
RAREUltragenyx Pharmaceutical Inc.60,308$1.3M
CRSPCRISPR Therapeutics AG26,078$1.2M
CRMDCorMedix Inc.175,011$1.2M
VSTMVerastem, Inc.221,323$1.2M
AGIOAGIOS PHARMACEUTICALS, INC.33,868$1.1M
BMYBRISTOL MYERS SQUIBB CO18,495$1.1M
QUREuniQure N.V.68,547$1.1M
BCRXBIOCRYST PHARMACEUTICALS INC113,881$1.1M
RIOTRiot Platforms, Inc.85,525$1.1M
RCKTRocket Pharmaceuticals Inc.287,815$1.0M
AKBAAkebia Therapeutics, Inc.633,253$880K
PRTAPROTHENA CORP PUBLIC LTD CO88,544$861K
NBIXNEUROCRINE BIOSCIENCES INC5,924$780K
WSTWest Pharmaceutical Services Inc.2,994$750K
RGNXREGENXBIO Inc.88,385$741K
EDITEditas Medicine, Inc.263,069$650K
IRWDIRONWOOD PHARMACEUTICALS INC184,485$648K
ALTAltimmune, Inc.201,989$622K
AUTLAutolus Therapeutics plc440,206$607K
GERNGERON CORP396,632$591K
CCCCC4 Therapeutics, Inc.223,168$587K
REGNREGENERON PHARMACEUTICALS, INC.712$550K
ORGOOrganogenesis Holdings Inc.210,826$500K
IDXXIDEXX LABORATORIES INC /DE842$473K
BHVNBiohaven Ltd.44,793$379K
NVONovo Nordisk A/S9,757$359K
GOSSGossamer Bio, Inc.828,719$272K
PRCTPROCEPT BioRobotics Corporation10,343$259K
NVSNovartis AG1,523$233K
SNYSanofi4,590$221K
PAHCPHIBRO ANIMAL HEALTH CORP3,669$203K
SDGRSchrodinger, Inc.15,021$171K
PLRXPLIANT THERAPEUTICS, INC.106,705$134K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Hennion & Walsh Asset Management, Inc. — Biotech 13F Holdings & Portfolio | BioSniper